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Abstract 
 
 For the last decade or so, in vitro toxicology has been studied as a method for 
determining human toxicity, as well as hazard identification and characterization. One 
purpose of in vitro studies is to determine the possibility of developing systems in which 
the toxicity of chemicals can be quantified, without heavy reliance on animal 
experimentation. Specific data pertaining to cadmium toxicity in humans through use of 
in vitro methods and models is sparse, at best. There is a need to complete more studies 
and collect more data to study particular chemicals and their effects and to complete 
proper evaluation and comparison to in vitro studies on human cells. The need for such 
data is the overall reason for this thesis research and experimentation. 
 Toxicology in vitro refers to a method of exposing cell tissue directly to the 
chemical compound under study. In this research, rat liver cells, or hepatocytes, were 
cultured, exposed to cadmium oxide particles, and analyzed with an MTT assay. The 
assay provided information on the effects of the particles on the mitochondria of the liver 
cells. Once the assay was completed, data was generated using a spectroflourometer to 
measure the optical density of the cells, and finally a pre-formulated Excel spreadsheet. 
The final data output showed doses vs. percent of control cells. Experiments were carried 
out with doses ranging from 0.001 µg/mL to 2.5 µg/mL for 6, 12, and 24 hours. Two cell 
densities were also studied for each experiment, 1,000,000 cells/mL and 500,000 
cells/mL, in order to ascertain the effects of toxicity on cell density. 
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IN VITRO TOXICITY OF CADMIUM OXIDE 
PARTICLES IN BRL 3A RAT LIVER CELLS 
 
 
I. Introduction 
1.1   Overview  
 Predicting the overall influence of any toxic chemical on the human 
physiological system is difficult. The most widely accepted estimates of toxicity 
to humans are based on extrapolation of laboratory animal bioassay data (Carere 
et al., 2002) rendering them less than completely accurate. This extrapolation does 
not effectively take into account the manner in which humans are exposed to the 
chemical, environmentally or occupationally, nor the exact mechanisms of action 
in the human body. Since there is a lack of certainty concerning how chemicals 
are metabolized in the body, safety factors and conservative estimates are used in 
calculating human risk when extrapolating from animal toxicity data. These 
toxicity estimates and their assigned safety factors are then translated by 
regulatory enforcement agencies into human occupational or environmental 
exposure standards.  
 Another and newer method of estimating chemical toxicity to humans is 
through the use of in vitro toxicity studies.  For example, some of those studies 
apply nanoparticles (particles in the 1-100 nanometer range) to immortalized 
Buffalo Rat Liver (BRL) 3A cells, namely rat hepatocytes (Hussain et al. 2004). 
In vitro studies are also conducted using immortalized rat lung cells or 
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macrophages (Hussain et al. 2004). These in vitro methods are gaining wide 
acceptance, although they are not seen as the ultimate and final goal for studying 
the toxic effects of chemicals to humans. In vitro toxicity of hepatocytes refers to 
simply applying the known toxin directly to the liver cells in the media, after the 
cells have attached to the plates.  
 Ideally, toxicity studies will eventually be conducted directly on human 
tissue, which has been immortalized, like the rat liver cells.  Use of immortalized 
human tissue would negate the need to study and sacrifice animals and would 
likely yield data that would accurately predict the effect of chemicals on human 
cells and tissues.  
1.2  Background  
 1.2.1  In Vitro Particle Studies, BRL 3A Cells.  
 In order to gain a general sense of toxicity along with a maximum quantity 
of data in a short period of time, the BRL 3A immortal rat liver cell line was 
selected as a convenient working model system to screen for particle toxicity. The 
selection of rat liver cells is justified, as exposure to particles is likely to have an 
impact on liver cells through ingestion. The BRL 3A liver cell line also provides 
the ability to screen several materials at a low cost in a relatively rapid time 
frame.    
 To date, there are only a few studies directly or indirectly investigating the 
toxic effects of materials and no clear guidelines are available to quantify these 
effects. However, many in vitro methods are used in the preliminary screening of 
compounds of pharmacological interest, or for safety assessment. In other cases, 
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they represent supplementary tools for gathering more information on the specific 
mechanisms involved in a toxic effect. These methods will provide guidance for 
further evaluation, if necessary, both by in vivo studies on animals, as well as on 
humans (Carere et al., 2002). Toxicity data concerning effects on basic cellular 
functions and/or structures has a good correlation with in vivo data concerning 
human lethal toxicity (Ekwall, 1999). 
  1.2.2 Analysis.  Analysis was accomplished with the MTT assay. This 
assay measures the mitochondrial function of the cells after they are exposed to the 
cadmium oxide, the particle of choice for this study, for the specified period of time. The 
MTT solution contains a tetrazolium salt which is reduced into an insoluble formazan 
product by the mitochodria of living cells. The reduction produces a noticeable color 
change in the solution.  
 
 1.2.3  Cadmium. Cadmium is a non-essential element occurring naturally 
in the earth’s crust (Verougstraete et al. 2002).  Cadmium occurs in high 
abundance in zinc and lead ores and in phosphate fertilizers (Garrett, 2000; 
McLaughlin and Singh, 1999). High concentrations of cadmium are also found in 
sewage sludge (Resource Sciences, 1997). Agricultural uses of phosphate 
fertilizers and sewage sludge, and industrial uses of cadmium have been identified 
as a major cause of widespread dispersion of the metal at trace levels into the 
general environment and human foods (Satoh et al., 2002). Cadmium has high 
rates of soil-to-plant transference compared with other non-essential elements. On 
the basis of typical concentrations, vegetables and cereals contain five times more 
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cadmium than fruit and the levels of cadmium in oil seeds and cocoa beans are 
five times higher than in vegetables and cereals. General population cadmium 
ingestion exceeds the recommended safe intake level of 70 µg per day (WHO, 
1989; IPCS, 1992) with vegetables and cereals found to be the most significant 
sources of cadmium in the diet. Considerable amounts of cadmium found in zinc 
supplements have also raised a concern for users (Krone et al, 2001). 
 Non-workplace exposure to cadmium has been linked to a variety of 
adverse health affects. These include the development and/or progression of 
diabetic renal complications, hypertension, osteoporosis, leukemia and cancer in 
several organs such as the lung, kidney, urinary bladder, pancreas, breast and 
prostate (IPCS, 1992; Bellinger et al, 2001; Jarup et al, 1998). Chronic exposure 
to low levels of cadmium in drinking water or the diet was found to cause 
hypertension in several experimental animal species including the monkey 
(Akahori et al., 1994), rat (Schroeder, 1964), rabbit and dog (Thind et al, 1970; 
Thind et al, 1973). Human population studies, however, have provided conflicting 
results regarding a role for environmental cadmium exposure in the development 
of hypertension. Moderate to high intakes of cadmium were found to be 
associated with hypotension in some studies (Nishijo and Nakagawa and 1996; 
Nishijo et al, 2000). 
 Although cadmium is currently considered to be a human carcinogen by 
the International Agency for Research and Cancer (Waalkes, Michael P., 2003), it 
may be inappropriate to conclude that sufficient evidence on carcinogenicity of 
cadmium in humans exists, due to a lack of epidemiological justification in recent 
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research studies (Satarug, et al., 2003). Since there are inconsistent reports on the 
relationship of cadmium exposure with the life expectancy of people living in 
cadmium-polluted areas (Satoh et al, 2002), further studies are needed for 
clarification.  
1.3  Problem Identification 
 Specific data pertaining to cadmium toxicity in humans through use of in 
vitro methods and models is sparse, at best. There is a need to complete more 
studies and collect more data to study particular chemicals and their effects and to 
complete proper evaluation and comparison to in vitro studies on human cells, 
when the time comes. The need for such data is the overall reason for this thesis 
research and experimentation. 
1.4  Research Questions/Objectives 
 The purpose of this research was to determine the effect of cadmium oxide 
particles on rat hepatocytes.  Specifically, the following research questions were 
addressed: 
 What are occupational and environmental sources of cadmium or 
cadmium oxide? 
 What is the cellular toxicity of cadmium oxide particles? 
 What is the effect of cell density on cadmium oxide toxicity? 
1.5  Research Approach 
 The first step in this research effort was to identify occupational and 
environmental sources of cadmium and cadmium oxide through a literature search 
and discussion with knowledgeable individuals.  Secondly, a literature search was 
6 
used to identify studies involving in vitro methods of cellular toxicity testing, 
specifically, studies examining cadmium. The third step in the research was to 
conduct laboratory experiments using rat hepatocytes and cadmium oxide 
particles.  The particles were purchased by the Air Force Research Laboratory and 
made available to the researcher. Specifically, culturing of hepatocytes was 
through the use of Ham’s F-12 media in 100 mL flasks. Once the cells had 
become confluent, a desired amount of cells was withdrawn from each flask and 
counted. Various 6-well plates were then seeded with the counted cells, starting 
with 1 million cells per well and working down, to achieve the desired densities. 
After seeding for 24 hours, the cells on plates were then dosed with a range of 
concentrations of cadmium oxide solution. 24–hour exposures of the cells to 
cadmium oxide were studied. The MTT assay wasused to determine the toxicity 
to cells after the exposure. Upon completion of the 24-hour experiments, 12-hour 
and 6-hour experiments were completed to obtain a comparison. After the assay 
was accomplished for each experiment, the cell mortality results were measured 
through use of a spectrofluorometer. The data was then transferred to a pre-
formulated Excel spreadsheet for graphical output.  
 
1.6  Scope of Research 
 This research has limited scope in several ways.   There are few cellular 
toxicity studies cited in the literature using in vitro methods, or those specifically 
involving cadmium. Consequently, efficient comparisons of data between 
literature sources and specific studies may not be effectively accomplished. Also, 
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a complete and thorough analysis of the toxicity of cadmium oxide on more than 
hepatocyte cells is beyond the scope of this thesis.  Neither tissue nor organ 
toxicity was addressed.  Additionally, the experimental data is always subject to 
errors in measurement and procedure.   
1.7   Significance 
 There is possibly a long road ahead for researchers to achieve statistically 
correct data on cadmium oxide toxicity, in order to gain more certainty for rat to 
human tissue extrapolations. The Air Force Research Laboratory, Wright-
Patterson Air Force Base, Ohio is attempting such research. The data presented in 
this study will contribute to the overall research team’s accomplishments and 
goals, potentially, ultimately influencing the occupational and environmental 
exposure standards set by the Air Force  
1.7 Overview of Document 
 The remainder of this thesis consists of four chapters. Chapter two reviews 
literature on in vitro toxicity and cadmium studies in order to gain a broad 
perspective on the overall research to include history, concerns, and goals set 
forth by professional researchers and toxicologists. Chapter three provides a 
detailed discussion of the methodology used in this research. Next, chapter four 
presents the data and analytical results. Finally, chapter five discusses conclusions 
and significance of findings. 
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II. Literature Review 
 
2.1 Introduction 
 This literature review describes in vitro and hepatocyte research and discusses the 
toxicology of cadmium and cadmium oxide. The review includes a general discussion of 
in vitro toxicology history and its outcomes as well as information concerning hepatocyte 
cell cultures. The toxicity of cadmium oxide is the focus of this research. Cadmium will 
be characterized with regard to its usage, carcinogenicity, and action in the body. The 
chapter is concluded with a summary of the revelations from the literature review. 
2.2 Hepatocyte Cell Culture 
 Monolayer cell cultures were used in this research effort. Descriptions of these 
cultures were from Jakoby et al.(1979) and Guillouzo et al.(1986).  Basic monolayer 
techniques are well established. The cells routinely studied in monolayer culture can be 
derived in the laboratory from primary cultures, or obtained from commercial suppliers 
and nonprofit organizations. Monolayer cell cultures are frequently established from 
single cell suspensions prepared by the dissociation of organ fragments. The cell 
preparation is inoculated into a culture vessel containing fluid medium and incubated in a 
controlled atmosphere. The viable cells then settle and attach to the inside surface of the 
flask (coated with substrate) within several hours. The resultant primary culture is a 
mixed cell population, which contains many of the cell types contained in the tissue of 
origin. In order to obtain a monolayer culture consisting of a single cell type, it is 
necessary to isolate that cell from the primary preparation. There are various methods of 
cell separation, which can be applied to the initial cell suspension prior to culture. 
Alternatively, the cell population can be enriched using in vitro methods that select cell 
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types based on their attachment or growth characteristics. In this case, hepatocytes, or 
liver cells, were the cells of interest. In mixed cell cultures they tend to overgrow the 
population and obscure other cell types.  
  Cell types which require attachment to a rigid substrate in order to replicate in 
vitro are classified as anchorage-dependent cells. The hepatocytes used in this study were 
cultures in flasks containing a substrate. The growth kinetics of cells in monolayer culture 
follow a characteristic pattern. The cells eventually enter a log phase of growth in which 
there is an exponential increase in cell number. During the log phase, the cells exhibit 
their highest metabolic activity. When culture conditions no longer support cell division, 
the population enters a stationary phase, during which the cell number remains constant. 
In the case of hepatocytes, the researcher would extract the cells just before the stationary 
phase, when the cells are said to be confluent. “Confluent” cultures occupy all available 
growth surface. If nutritional conditions are adequate, a confluent cell population may 
continue to replicate in log phase. In practice, however, cells are not used beyond the 
point of confluency since essential metabolites are rapidly depleted at high cell density. 
 The physical culture environment should be well defined and precisely controlled. 
For example, optimum pH of the culture medium is usually within the range of 7.2-7.5. 
The determination of proper pH in a culture system is dependent on the cell type.  
Hepatocytes specifically require a pH of 7.25. Humidity and temperature in the incubator 
also play an important role in the integrity of the culture environment. 
 Subculturing or passaging cells involves detaching the cells from their substrate 
and transferring them to new culture vessels. This is done when cells have utilized the 
growth surface available to them. Various methods can be used to remove cells from the 
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culture surface. One method, proven as one of the less disruptive to the cells, is 
dissociation with a proteolytic enzyme such as trypsin. However, enzymic dissociation 
can still damage cells after a period of time, so it is desirable to minimize the duration of 
contact between the cells and enzyme solution. For hepatocytes, 2-3 hours is the optimal 
contact time. 
2.3 In Vitro Toxicity 
 For the last decade or so, in vitro toxicology has been studied as a method for 
determining human toxicity, as well as hazard identification and characterization. 
Currently, toxicological hazard and risk assessments are mainly based on highly 
standardized protocols for animal experimentation and exposure assessments. (Holme et 
al., 2002)  One purpose of in vitro studies is to determine the possibility of developing 
systems in which the toxicity of chemicals can be quantified, without the heavy reliance 
on animal experiments. 
2.3.1 History 
 Only a few in vitro toxicology tests are accepted by regulators. Many others are in 
the pre-validation or validation phase. An area where in vitro tests play a key role is 
genetic toxicology. In vitro methods are also used in the preliminary screening of 
compounds of pharmacological interest, or for safety assessment (Blaauboer, 2001).  
 The three critical aspects for success of in vitro tests are the availability of new 
methods, the validation of new test procedures, and the definition of criteria of 
acceptance by regulators. (Carere et al., 2002).  
11 
 Several in vitro cellular experimental models have been made available in the last 
four decades (Zucco et al., 1998), which are more or less representative of various cell 
types. Most of these cellular models are cell lines, immortal and often tumour-derived. 
 An in vitro model for skin absorption is now available and is being considered for  
inclusion in the OECD (Organization for Economic and Co-operation Development) 
guidelines. It has been considered scientifically validated by ESAC (European 
Surveillance of Antimicrobial Consumption) very recently. Several, in vitro skin irritation 
models are currently available and used for research. Only the protocols of three 
commercial kits have been judged ready for a pre-validation study (Van de Sandt et al., 
1999). 
 In genetic toxicology, the primary objectives of in vitro tests are identification of 
potential germ cell or somatic cell mutagens (potential carcinogens). In general, at least 
two in vitro tests, one at the gene level in bacteria and one at the chromosome level in 
mammalian cells, are considered necessary for chemicals of limited or absent human 
exposure (Carere et al., 1995). In the case of chemicals for which direct human exposure 
is expected, several testing strategies have been proposed with 3-4 tests at the gene and at 
the chromosome level, often also including an in vivo assay (Carere et al., 1995; Muller 
et al., 1999; COM, UK, 2000). 
The recently updated guideline for food additives by the E.C. Scientific 
Committee on Food (Carere et al., 2002) recommends the following standard battery of 
three in vitro tests: 
1. A test for the induction of gene mutations in bacteria. 
2. A test for the induction of gene mutations in mammalian cells. 
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3. A test for induction of chromosomal aberrations in mammalian cells. 
In general, this battery is considered sufficiently sensitive to detect the most genotoxic 
compounds. 
2.3.2 Risk Assessment and Hazard Identification 
 Toxicological risk evaluation traditionally relies on a wide array of animal 
experiments. The day-to-day practice of these procedures have led to the relatively safe 
use of chemicals in industry, or as agrochemicals, drugs, household chemicals, or 
cosmetics. However, large numbers of laboratory animals have been used and distress 
caused to many of these animals (Anonymous, 1986). Besides the ethical objections 
against the use of animals, there is also a scientific motivation for criticizing the heavy 
reliance on animal data, which has always been prone to some degree of uncertainty. 
 In vitro systems have been extremely useful in studying the molecular basis of a 
chemical’s biological activity, including its mechanisms of toxic action (Blaauboer et al., 
1998). Knowledge of a compound’s mechanism of toxic action, either derived from in 
vitro studies or based on its structure, can be the basis of hazard identification. However, 
a hazard assessment cannot easily be made without further knowledge of the compound’s 
behavior in the integrated system of an intact organism. Thus, results obtained from in 
vitro studies in general are often not directly applicable to the in vivo situation. One of the 
most obvious differences between the situation in vitro and in vivo is the absence of 
processes regarding absorption, distribution, metabolism and excretion that govern the 
exposure of the target tissue of the organism in vivo (Flint, 1990; Blaauboer et al., 1990).  
From this description, it is clear that the information derived from in vitro toxicity 
studies will be useful for studying toxic mechanisms of chemicals on the cellular and 
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molecular level. However, this information then needs to be interpreted taking into 
account the compounds’ behavior. 
 Walton et al., (1999) reviewed  the application of in vitro data in the derivation of 
the acceptable daily intake of food additives and concluded that in vitro metabolism and 
mechanistic studies in isolation have limited value for the prospective toxicological 
classification and characterization of food additives. However, in conjunction with 
detailed short- and long-term in vivo studies, tests can be used in the calculation of both 
inter-species and inter-individual variability in the toxicokinetics and toxicodynamics of 
food additives. Thus, in vitro studies may assist in removing some of the uncertainty 
involved in extrapolating toxicity from the most sensitive test species to humans. 
2.3.3 Extrapolation From High to Low Dose  
 Often there are differences in the toxicodynamics of a chemical revealed at high 
doses compared to that operating at lower doses. One example is bis(tri-n-butylin)oxide 
(TBTO), mainly used as a biocide in crop protection and antifouling paints for large 
ships. In vitro studies showed low concentrations of TBTO effectively inhibit DNA 
synthesis and cell proliferation (Vandebriel et al., 1999). At higher concentrations of 
TBTO, the cells die (Stridh et al., 1999). These in vitro findings parallel in vivo findings 
in the rat. There is also an example of in vitro studies supporting in vivo studies in the 
case of paracetamol, showing the mechanism of action at both high and low doses 
(Davies et al., 1986). 
2.3.4 Conclusion   
In vitro studies can never, in isolation, determine the exact level of zero adverse 
toxicity for threshold compounds or risk specific doses for non-threshold compounds. 
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However, in vitro systems will aid in the identification of the most sensitive species or 
strain. Also, in vitro systems are good models for studying qualitative and quantitative 
species differences in toxicity. Further, in vitro systems are excellent models for 
characterization of the mode of action/mechanism for critical effects, but findings need to 
be validated in vivo. Finally, in vitro systems will aid in the extrapolation from high to 
low dose and from experimental animal to humans.  
2.4 Cadmium 
 Cadmium is an abundant transition metal of worldwide concern because it 
accumulates in the environment as a result of its numerous industrial uses. In humans, 
non-occupational exposure results predominantly from the consumption of contaminated 
food, from smoking as a result of the uptake of cadmium from tobacco plants in 
contaminated soil, and from inhalation of polluted air. Cadmium has an extremely long 
biological half-life that essentially makes it a cumulative toxin and, at present, there is no 
proven effective treatment for chronic cadmium intoxication. Occupational exposure to 
cadmium is associated with lung cancers in humans, while impacts on organs, such as the 
prostate, have not been established (Waalkes, 2000). Due to multiple regulations on the 
use of cadmium compounds, their industrial uses, and further dispersion in the 
environment, have been sharply curtailed in the last 10 years. However, cadmium is an 
extremely persistent element, which, once introduced to the environment, will persist for 
centuries (Filipi et al., 2003).  
As far as environmental sources, plants can take up cadmium from soil, and fish 
can take it up from water. Phosphate fertilizers and sewage sludge may also increase 
cadmium levels in soils, which can increase it in crops (Saturug et al., 2003). The largest 
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source of cadmium is from the burning of fossil fuels (coal and oil) or incineration of 
municipal waste materials (Waalkes, 2002). The US Environmental Protection Agency 
has listed cadmium 7th on the superfund hazardous list. 
2.4.1 Chemical Characteristics 
 Table 2.1 is extracted from the NIOSH Pocket Guide to Chemical Hazards, 1997 
and discusses attributes of cadmium. 
Table 2-1.  Extract from NIOSH Pocket Guide to Chemical Hazards, 1997 
Chemical Name Synonym/Trade 
Name 
Physical 
Description 
Incompatibilities 
and Reactivities 
Cadmium dust (as 
Cd) 
Cadmium metal; 
Cadmium, others 
depending on 
compound 
Silver-white, blue-
tinged, lustrous, 
odorless solid 
Strong oxidizers, 
elemental sulfur, 
selenium, tellurium 
Cd (Metal) Cadmium metal; 
Cadmium, others 
depending on 
compound 
Silver-white, blue-
tinged, lustrous, 
odorless solid 
Strong oxidizers, 
elemental sulfur, 
selenium, tellurium 
Cadmium fume (as 
Cd) 
Cadmium 
monoxide, cadmium 
oxide fume, 
cadmium 
Odorless, yellow-
brown, finely 
divided particulate 
dispersed in air 
Not applicable 
 
2.4.2 Mutagenicity 
 Cadmium and cadmium compounds are suspected human carcinogens and are 
ubiquitous in the environment. Cadmium has been classified as a human carcinogen by 
the International Agency for Research on Cancer (IARC). The carcinogenic mechanisms 
of cadmium remains largely unknown since direct mutagenic effect is weak in bacterial 
and standard mammalian cell mutation assays. Cadmium has been shown to induce 
chromosomal aberrations, sister chromatoid exchanges, DNA strand breaks, and DNA-
protein crosslinks in various mammalian cell species. Cadmium has also been reported to 
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be co-mutagenic in combination with either UV irradiation or other chemical 
carcinogens. 
 In a study conducted by Filipi et al., (2003), using a human-hamster hybrid cell 
line, cadmium chloride was found to induce a dose and time dependent increase of 
mutations in the cells. In a 5 hour exposure, 34 mutants per 105 survivors per µM CdCl2 
and 147 mutants per 105   survivors per µM CdCl2 in a 24 hour exposure were observed.  
 There is evidence that cadmium interferes with several DNA repair mechanisms 
including the repair of oxidative DNA damage (Hartwig, 1994). These and the 
aforementioned results indicate that cadmium is a potent mutagen in cultured mammalian 
cells. In the human-hamster hybrid cells it induced mutations at concentrations 
comparable to those found in the environment and at the levels that can accumulate in the 
human body (IARC,1993).  
2.4.3 Other Health Hazards 
 Cadmium can enter the bloodstream by absorption from the stomach or intestines 
after ingestion of contaminated food or water, or by absorption from the lungs after 
inhalation. Once in the body, cadmium is very strongly retained. So even small doses 
build up significantly during continuous exposure (Elliot at al., 2000). The amount of 
cadmium needed to cause adverse health effects depends on the physical form (Satoh et 
al., 2003). 
Table 2.2 is extracted from the NIOSH Pocket Guide to Chemical Hazards, 1997 
and lists the known hazards of cadmium. 
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Table 2-2. Extract from NIOSH Pocket Guide to Chemical Hazards, 1997. 
Chemical Name Symptoms Target Organs Route 
Cadmium dust (as 
Cd)  
Pulmonary edema, 
cough, chest 
tightness, 
headaches, chills, 
muscle aches, 
nausea, vomiting, 
diarrhea, mild 
anemia  
Respiratory system, 
kidneys, prostate, 
blood 
Inhalation, Ingestion
Cd (Metal) Pulmonary edema, 
cough, chest 
tightness, 
headaches, chills, 
muscle aches, 
nausea, vomiting, 
diarrhea, mild 
anemia 
Respiratory system, 
kidneys, prostate, 
blood 
Inhalation, Ingestion
Cadmium fume Pulmonary edema, 
cough, chest 
tightness, 
headaches, chills, 
muscle aches, 
nausea, vomiting, 
diarrhea, mild 
anemia 
Respiratory system, 
kidneys, prostate, 
blood 
Inhalation 
 
2.4.4 Occupational Exposure 
 The IARC noted  several constraints influencing their evaluation of cadmium, 
which, to a large extent, was based on animal experiments where the animals 
predominantly were exposed to inhaled or injected cadmium. The epidemiological 
evidence originates from occupationally exposed workers, with sparse historical data on 
exposure to cadmium, rarely accounting for confounding factors (such as smoking) 
(Elliot et al., 2000). 
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 In a study conducted by Aizenburg et al., 2000, personal exposure of workers 
performing abrasive blasting operations (a common method of corrosion control and 
surface preparation) at four U.S. Air Force facilities was monitored. Airborne dust was 
generated through these operations and were inhaled by the workers. The aerosols from 
the dust were found to contain 25 metals, including cadmium. Even workers wearing 
respirators and blasting helmets were exposed to high cadmium levels (relative to the 
Threshold Limit Value) because of the presence of large cadmium-plated parts and 
several small cadmium-plated subsections and rivets. Overall, the measured 8-hr Time 
Weighted Average for airborne concentrations was higher than the Permissible Exposure 
Limits (PEL) of 0.005 mg/m3 for nine out of ten tasks.  
 In the “Rapid Guide to Hazardous Chemicals in the Workplace” (Lewis, 1994), 
cadmium is listed with various safety profiles.  Pure cadmium in the form of dust is a 
confirmed human carcinogen.  The Time Weighted Average (TWA) according to OSHA 
PEL is 5 µg Cd/m3. For cadmium compounds, in the form of dust and salts, the safety 
profile and TWA are the same as that for pure cadmium. 
 According to Levy and Wegman, (1995), construction workers also encounter 
cadmium in the work place. Welding and cutting pipe can produce metallic dusts and 
fumes. The authors state that cadmium exposure occurs in many other industrial 
processes, and can be monitored with either urine or blood concentrations. Cadmium is 
also commonly obtained as a by-product from smelting of zinc, lead, or copper ores and 
is used in metal plating, pigments, batteries, and plastics (Saturug et al., 2003). 
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2.5 Summary 
 Exposure to cadmium fumes and dust has been associated with lung cancers and 
various cadmium compounds have displayed genotoxic potential. Further efforts are 
necessary to define more precisely the risks of cancer from cadmium exposure and its 
target sites in humans. Exposure can also lead to many other health concerns. There is no 
real rationale to the belief that cadmium acts the same way in all target tissues, and it is 
quite plausible that multiple, target tissue- specific mechanisms apply (Waalkes, 2003). 
Obviously, this heavy metal has become a considerable environmental and occupational 
concern. Unfortunately, there are no proven effective treatments for chronic cadmium 
intoxication (Goering, et al., 1994). More research is needed, not only understand the 
behavior of cadmium in various environments, but also to know how to effectively deal 
with all exposure levels to the human body. 
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III. Methodology 
 
3.1 Introduction 
 The primary goal of this research effort was to determine cadmium oxide particle 
toxicity to rat liver cells in culture.   The research was carried out by conducting 
laboratory experiments with cadmium oxide solutions, using an in vitro toxicity method 
with analysis using an MTT assay. Cadmium was chosen because of the availability of 
research on the particles as well as a lack of solid conclusions as to the effects cadmium 
has on the human body. Cadmium oxide was also chosen for exposures of the cells 
because the Air Force Research Laboratory is already pursuing studies using this 
particular compound. The appeal of the in vitro method is the novelty of an emerging 
field of study. While there have been numerous studies conducted using in vitro 
techniques, there is still a lack of research data in this area compared to other toxicity 
studies.  
The overall laboratory experiments consist of three general steps; cell culture 
preparation, exposure of cells to cadmium oxide particulates, and analysis of cell 
mortality using the MTT assay.  These steps are detailed later in the chapter. First, 
assumptions made in conducting the research are detailed, then lab equipment described, 
components of media listed, and the final data output technique described. The 
methodology will conclude with a brief summary. 
3.2 Assumptions 
 Several key assumptions were made at the beginning of the laboratory 
experiments. 
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1) Precedents set forth by professional researchers in previously 
conducted in vitro toxicity tests were accurate.    
2) Cadmium oxide concentrations in solutions were selected based upon 
previous work and applied during this experiment. The concentrations 
calculated by former professional researchers were assumed to be 
accurate for the purposes of this study. 
3) Despite the lack of solid evidence as to all the effects of cadmium on 
the human body, cadmium oxide was treated as a suspected carcinogen 
in this study. 
4) The concentrations of dose-metrics have the same cancer-causing 
potential in humans as in rats, an assumption generally accepted by 
both regulatory agencies and researchers. 
3.3 In Vitro Testing 
 There are some examples of in vitro studies that indicate comparative in vitro 
studies using cellular systems from experimental animals and humans can aid in the 
extrapolation of animal data to humans (Holme et al., 2002). Further in vitro results may 
reduce uncertainties in these quantitative extrapolations. Further, in vitro models have 
been shown, to some extent, to be excellent models for characterization of the mode of 
action for critical effects, however, the findings still need to be validated by in vivo 
methods, a long established procedure. 
 In vitro experiments involve a methodology for studying toxic effects, which is 
currently being employed in various studies to include cellular systems, genetics, and 
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stem cell research (Zucco et al., 1998; Kulyk et al., 2000). For this particular study, only 
immortalized rat liver cells were used.  
 The method of experimentation involved first culturing the cells, in an effort to 
achieve the appropriate cell density for each experiment. The cell densities required were 
1,000,000 cells/mL and 500,000 cells/mL. Both densities were used at the same time for 
each experiment, for comparison. Therefore, for each experiment, one control was run for 
each of two cell densities.  Each was at least done in triplicate.  Once the 6-well plates 
were properly seeded with these cells (cells attached to the bottom of each well in the 
plate), the growth media was suctioned out, leaving the cells attached to the bottom of the 
plates. Immediately, the required doses of cadmium oxide solutions were applied directly 
to the cells in the plates. The plates were then incubated for the specified period of time 
unique to the particular experiment. After the end point had been achieved, the cadmium 
oxide solution was suctioned out, again leaving the cells attached to the plates. After 
which, the MTT assay (discussed later in the chapter) was applied to measure the 
mitochondrial function of any living cells remaining after the exposures. 
3.4 Cellular Line/System Used 
 Through numerous research studies previously performed at the Air Force 
Research Laboratory, the suggested cell line for this study was the BRL-3A (Buffalo Rat 
Liver) cell line. For the purposes of this study, the actual process of retrieving the cells 
out of the animal and immortalizing them was not observed. The liver cells were stored 
and transported from the vivarium (located in a separate section of the Air Force 
Research Laboratory) to the appropriate lab in a nitrogen tank. There, the tubes of cells 
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were extracted from the tank by hand and allowed to thaw in the incubator, to prepare for 
culture. 
3.5 Cell Culture 
 Once the cells had been thawed, they were placed in a specified number of 100 
mL flasks, the number being unique to the particular experiment. Each flask was then 
trypsinized (injected with trypsin and Ham’s F-12 media with serum), to allow the cells 
to attach to the walls of the flasks and grow (Guillouzo, et al., 1986). 
 Throughout the process of culturing cells, it became necessary to continuously 
trypsinize the cells, in an effort to prevent them from overgrowing (becoming too 
confluent) in the flasks, and also to extract cells to use for the exposures and/or split the 
cells into a higher number of flasks.  
The trypsinization process was completed as follows: 
1. Growth media suctioned from each flask  
2. 10 mL of Phosphate Buffered Saline (PBS) was injected into each 
flask. The PBS was allowed to coat and wash the cells briefly (a few 
seconds) before being suctioned out.  
3. 1.5 mL of trypsin was added and also allowed to thoroughly coat the 
cells. The flasks were incubated with the trypsin for 3-4 minutes. This 
allowed the cells to detach from the walls of the flask as well as each 
other.  
4. 5 mL of Ham’s F-12 growth media was added to each flask.  
5. Media was sprayed up and down the walls of the flask to re-suspend 
the cells more uniformly at the bottom of the flask and in the media.  
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6. A desired amount of media containing cells was withdrawn from the 
flasks and either placed in new flasks, or counted and placed into 6-
well plates for exposure, or both.  
7. Each remaining flask, including old flasks,  then received an injection 
of 10 mL of Ham’s F-12 growth media. The amount of media added to 
the exposure plates depended on what amount of media containing 
cells was originally added to the plates. This amount would be 
determined by counting the cells using a matrix plate under the 
microscope. Which of these options would be utilized varied from day 
to day, depending on the demands of the experiments.  
8. All flasks and plates were then incubated for 3-4 hours, to allow the 
cells to attach to the walls of the flasks and/or the bottom of the plates. 
9. The final step of the process was to suction out all media with the 
trypsin, and inject the same amount of fresh Ham’s F-12 growth media 
because trypsin becomes toxic to the cells after a period of time and 
inhibits cell growth. Cells were then allowed  to grow until the next 
appointed time to reaccomplish the  entire process.  
Trypsinization was accomplished as frequently as necessary  to prevent cells from 
becoming too confluent. The  number of flasks could be increased at any time, thus 
increasing the availability of cells for experiments, through the trypsinization process. 
3.6 Lab Set-Up 
 ---Spectromax 190 – The spectrofluorometer (or Spectromax)  was used in the 
data analysis, after completing the assay.  The Spectromax measures fluorescence, light 
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emitted by certain substances (in this case, cells) resulting from the absorption of incident 
radiation (Spectromax 190 Operator’s Manual). The machine employs the use of an 
excitation spectral scan, which measures fluorescence at a single wavelength across a 
spectrum of excitation wavelengths. The default value reported for each well in the plate 
is the excitation wavelength of maximum fluorescence. An integrated software program 
is used to control and collect data from the instrument and display the data in tabular 
form on the computer screen.   
 ---Microscope Analysis- Use of the microscope showed the affects of the toxin 
on exposed cells versus the control cells. However, this would not be sufficient data on 
its own. 
  ---Media- A description of all media used in the study is listed in Table 3-1. 
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Table 3-1.  Media used for cultures.   
Media Name Ingredients 
Ham’s F-12 
Growth Media 
(pH 7.25) 
900 mL 
de-
ionized 
water 
1.2g sodium 
bicarbonate 
1 L 
Dulbecco’s 
Modified 
Eagle’s 
Medium 
Nutrient 
Mixture F-12 
Ham 
15 mL 
Penecillin/Streptomyacin 
30 mL 
Fetal 
Bovine 
Serum 
Ham’s F-12 
Exposure 
Media (pH 
7.25) 
900 mL 
de-
ionized 
water 
1.2g sodium 
bicarbonate 
1 L 
Dulbecco’s 
Modified 
Eagle’s 
Medium 
Nutrient 
Mixture F-12 
Ham 
15 mL 
Penecillin/Streptomyacin 
Acidified IPA 
(Isopropanol) 
200 mL 
de-
ionized 
water 
1.65 mL 
HCL 
300 mL 
isopropanol 
PBS 
(Dulbecco’s 
Phisphate 
Buffered 
Saline) 
900 mL 
de-
ionized 
water 
1 L PBS 
concentrated 
powder 
Trypsin 90 mL 
PBS 
10 mL stock 
trypsin 
Tetrazolium 
Salt MTT 
20 mL 
PBS 
100 mg MTT 
Sigma cat. 
No. M-5655 
 
Additional equipment was used during the experiments including a Corning  pH 
Meter 220 (AAMRL 10422) used for preparing Ham’s F-12 media, an incubator 
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maintained at 37 degrees Celsius, and utensils to include  6- well plates, electric pipetter, 
hand pipetters, 100 mL flasks, 96-well plates 
 
3.7 Exposures   
 3.7.1 Cadmium Oxide Solutions 
  Raw cadmium oxide particles were made into a 1 mg/mL stock solution. 
Two experiments were conducted, one with high-concentration range doses, one with 
lower concentrations.  The amount of media and stock solution used for each 
concentration is shown in Table 3-2 and 3-3. 
Table 3-2.  Media and stock solutions used to prepare exposures. 
Concentrations for high-dose range 
(µg/mL) 
0 10 mL exposure media 
0.1 1 uL of 1 mg/mL stock solution in 10 mL 
exposure media 
0.25 2.5 uL of 1 mg/mL stock solution in 10 mL 
exposure media 
0.5 5 uL of 1 mg/mL stock solution in 10 mL 
exposure media 
1.0 10 uL of 1 mg/mL stock solution in 10 mL 
exposure media 
2.5 25 uL of 1 mg/mL stock solution in 10 mL 
exposure media 
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Table 3-3.  Media and stock solutions used to prepare exposures. 
Concentrations for low-dose range 
(µg/mL) 
0 10 mL exposure media 
0.001 10 ul of 1 ug/mL stock solution (made with 
serial dilution from 1 mg/mL stock) in 10 
mL exposure media 
0.01 10 uL of 10 ug/mL stock solution (made 
with serial dilution from 1 mg/mL stock)10 
mL exposure media 
0.1 10 uL of 100 ug/mL stock solution (made 
with serial dilution from 1 mg/mL stock)10 
mL exposure media 
0.5 5 uL of 1 mg/mL stock solution in 10 mL 
exposure media 
1.0 25 uL of 1 mg/mL stock solution in 10 mL 
exposure media 
 
 After the 6-well plates were seeded with the desired cell densities, the growth 
media was suctioned out and replaced with 1 mL of cadmium oxide solution (one 
concentration per well).  
 3.7.2 End Points 
 The experiments started with 24-hour incubations with the high and low dose 
ranges. This was followed with experiments of 12-hour incubations with both dose 
ranges. Each dose range was applied to three 6-well plates for each end point. This entire 
experiment was then repeated at least twice more, for a total of not less than 9 plates per 
dose range per end point.  The results of the first experiments dictated which end point to 
study next. For example, if the high-dose 12-hour experiment showed similar results to 
the 24-hour experiment, then the next end point would be at 6 hours. The same method 
was applied to the lower dose range. The purpose of these end points was to make an 
attempt to discover the amount of time at which the cadmium oxide would start to 
become toxic between 0 and 24 hours after exposure.  
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 3.8 MTT Assay 
 After all experiments were completed, the MTT assay was performed.  The MTT 
is useful for assaying cell survival and proliferation after exposure to the toxin. MTT 
assay represents the mitochondrial function of the cells. (Romijn et al., 1988) This assay 
is a colorimetric assay system, which measures the reduction of a tetrazolium component 
into an insoluble formazan product by the mitochondria of viable cells. Cells with 
functional mitochondria convert the tetrazolium dye into its reduced form. The amount of 
the resulting bluish-purple color is directly proportional to the number of viable cells. The 
color change is measured spectrophotometrically in the Spectromax 190 micro plate 
reader.  The MTT procedure is listed following. 
 3.8.1 MTT Procedure 
1. Suction media from plates 
2. Add 1 mL MTT solution and incubate for 20-30 minutes 
3. Suction MTT solution 
4. Add 1 mL  acidified IPA to the plates 
5. Shake the plates for 15 minutes on VWR Vortexer to obtain homogeneous 
staining 
6. Transfer 200 uL from each well to a corresponding well in 96-well plate 
7. Read the plate in Spectramax 190 micro plate reader 
After the assay was completed, the researcher observed cell death via the color 
change before reading the plate in the  Spectromax 190. The data from the Spectromax 
was then converted into the final graphical output.   
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3.9 Data Output 
 After the Spectromax 190 generated the data from each experiment, the data was 
then entered into a pre-formulated Excel spreadsheet. The formulas converted the raw 
data into graphical output, measuring concentrations of cadmium oxide solutions against 
percent of control cells on the axes. The graphs depicted both cell densities and were 
generated the same way for all experiments and end points. 
3.10 Summary 
 The three general steps for these experiments were conducted as identically as 
possible for each experiment. The method used was a pre-existing method carried out by 
the Air Force Research Laboratory in on-going studies. There have already been studies 
conducted in this laboratory using in vitro techniques, however, researchers still have a 
long way to go to reaching definitive conclusions. The experiments conducted for this 
thesis research will hopefully provide additional data for AFRL and contribute to their 
growing efforts in the in vitro field.  
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IV. Data Description and Analysis 
 
4.1 Introduction 
 
This chapter will present the data gathered during the execution of the  
methodology. The information resulting from each individual end point and dose 
range, from highest to lowest is presented first. For example, data will be analyzed 
first from the 24 hour experiments with the higher dose range, followed by the lower 
dose range at the same end point. The 12 hour and 6 hour data will be presented in the 
same fashion. A combination of all the data at each end point and dose range will also 
be presented and analyzed. Each graph will include confluent cell toxicity (1,000,000 
cells/mL) and semiconfluent cell toxicity (500,000 cells/mL). A discussion of the data 
will follow this section. The chapter will conclude with a brief summary.  
4.2 Cadmium Oxide Toxicity Data 
The following graphs will be presented in the order in which the experiments 
were completed. The graphs depict the dose range at which the cells were 
exposed, versus the percent of the unexposed control cells remaining after 
exposure. From chapter three, each set of data is a result of the MTT assay. 
4.2.1 Toxicity over 24 Hours  
 
The following data reflect the effects of CdO exposure on rat 
hepatocyte cells over a period of 24 hours. The data was generated 
following completion of the MTT assay. The data is presented in order 
from the higher dose range (0.1 – 2.5) µg/mL to the lower dose range 
(0.001 – 1) µg /mL. 
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4.2.1.1 High Dose Range 
 
 24-hour high dose range results are shown in Figure 4-1. An anomalous 
positive activity is observed at 0.1 µg/mL for the confluent cells (compared to 
later experiments). For both cell densities, the toxicological affects seemed 
less adverse at 0.5 µg/mL than at 0.25 µg/mL. With the exception of these 
observations, a somewhat smooth dose-response curve can be seen for both 
cell densities. On average, the semiconfluent cells show more resistance to the 
toxicant than the confluent cells. For example, at 2.5 µg/mL, semiconfluent 
shows 3.0% of control cells while confluent shows 1.6% of control. 
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Figure 4-1.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 24 hour exposure ending on 26 Oct 04. 
 
 More 24-hour high dose results are shown in Figure 4-2. The confluent 
cells seem to show more resistance to the toxin than the semiconfluent cells. 
Once again, 0.5 µg/mL was observed to be less adverse than 0.25 µg/mL. 
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With the exception of this observation, a smoother dose-response curve is 
observed for this experiment than for the previous data. 
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Figure 4-2.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 24 hour exposure ending on 28 Oct 04. 
 
  For the third experiment, the semiconfluent cells show  more resistance to 
the toxin than the confluent cells (Figure 4-3). The same observations at 0.5 
µg/mL presented in the previous sets of data is once again made here. With 
the exception of that observation, a smooth dose-response curve is observed. 
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Figure 4-3.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 24 hour exposure ending on 9 Nov 04. 
 
  
4.2.1.2 Low Dose Range 
 
For this experiment, 24-hour low dose experimental results are shown in Figure 4-
4. A large drop in resistance is seen in both cell densities between 0.001 ug/mL and 
0.01 µg/mL. At 0.001 µg/mL, the cells seem less adversely affected than at 0.01 
µg/mL. On average, the confluent cells show more resistance to the toxicant than the 
semiconfluent. 
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Figure 4-4.  Effect of CdO, with doses ranging from 0.001 – 1 µg /mL, on hepatocytes 
following a 24 hour exposure ending on 16 Dec 04. 
 
 
4.2.1.3 Combination of 24 Hour Experiments 
 
Figure 4-5 shows the combined data for 24-hour experiments. A dramatic reaction 
of both cell densities at the duplicate dose of 1.0 µg/mL CdO, and 2.5 µg/mL 
(compared to the other doses) was observed.  The experiments revealed the most 
consistency with these doses than with any of the others. There appears to be an 
anomaly at 0.1 µg/mL, in that the confluent cells showed a slight positive activity. 
Also, the effects at 0.01 µg/mL are more adverse than at many of the major 
concentrations. As observed in all of the previous data, the dose of 0.5 µg/mL is less 
toxic to the cells than 0.25 µg/mL. 
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Figure 4-5. Combination of all 24 hour experiments conducted on CdO exposure,     
with doses ranging from 0.001 – 2.5 µg /mL. 
 
 
4.2.2 Toxicity over 12 Hours 
 
The following data reflect the effects of CdO exposure on rat 
hepatocyte cells over a period of 12 hours. The data was generated 
following completion of the MTT assay. The data is presented in order 
from the higher dose range (0.1 – 2.5) µg/mL to the lower dose range 
(0.001 – 1) µg/mL. 
 
4.2.2.1 High Dose Range 
 
The 12-hour exposure data from the first high dose experiment is shown in 
Figure 4-6. As in the 24 hour experiments, the cells show more resistance to 
0.5 µg/mL CdO than they do at 0.25 µg/mL.  Otherwise, a typical dose-
response curve is observed. On average, the confluent cells show more 
resistance to the toxin than the semiconfluent cells.  
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Figure 4-6.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 12 hour exposure ending on 15 Dec 04. 
 
 The results of a second 12-hour high dose experiment is shown in Figure 
4-7. The confluent cells now show more resistance to the dose of  0.25 µg/mL 
than at 0.1 µg/mL. For the semiconfluent cells, the effect observed at 0.5 
µg/mL shown in all of the previous experiments is also shown here, in that the 
cells are more resistant at 0.5 µg/mL than at 0.25 µg/mL. On average, the 
confluent cells show more resistance to the CdO than the semiconfluent. 
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Figure 4-7.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 12 hour exposure ending on 17 Dec 04. 
 
 Another 12-hour low dose experiment is shown in Figure 4-8. As in the 
previous one, the confluent cells once again show more resistance at 0.25 
µg/mL than at 0.1 µg/mL. The confluent cells also show more resistance at 0.5 
µg/mL than at 0.1 µg/mL, but less resistance at 0.5 µg/mL than at 0.25 µg/mL. 
For the semiconfluent cells, the previous observations at 0.5 µg/mL holds 
here. On average, the confluent cells show more resistance to CdO than the 
semiconfluent. 
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Figure 4-8.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 12 hour exposure ending on 4 Jan 05. 
 
4.2.2.3 Low Dose Range 
 
Figure 4-9 shows the results of a 12-hour low dose experiment. The 
confluent cells show more resistance at 0.1 µg/mL than at 0.01 and 0.001 
µg/mL. For the semiconfluent cells, the only observation disrupting the dose-
response curve is more resistance at 0.1 µg/mL than at 0.001 and 0.01 µg/mL. 
On average, the semiconfluent cells show more resistance than confluent cells. 
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Figure 4-9.  Effect of CdO, with doses ranging from 0.001 – 1 µg /mL, on 
hepatocytes following a 12 hour exposure ending on 17 Dec 04. 
 
  Figure 4-10 shows the second 12-hour experiment with a low dose. The 
confluent cells show more resistance at 0.1 µg/mL than at 0.001 and 0.01 
µg/mL. The same observation is made for 1 µg/mL versus 0.5 µg/mL. For the 
semiconfluent cells, the most resistance to the toxin is observed at 0.01 
µg/mL. In addition, 0.1 µg/mL is seen to be slightly less toxic than 0.001 
µg/mL. On average, the confluent cells show more overall resistance than the 
semiconfluent cells. 
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Figure 4-10.  Effect of CdO, with doses ranging from 0.001 – 1 µg /mL, on 
hepatocytes following a 12 hour exposure ending on 12 Jan 05. 
 
  
Figure 4-11 shows the results of the final 12-hour low dose exposure. The 
confluent cells show less resistance to CdO at 0.001 µg/mL than at 0.01 and 
0.1 µg/mL. However, the semiconfluent cells show a steady decline in 
resistance as the doses get higher. On average, the confluent cells show more 
overall resistance than the semiconfluent cells. 
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Figure 4-11.  Effect of CdO, with doses ranging from 0.001 – 1 µg /mL, on 
hepatocytes following a 12 hour exposure ending on 17 Jan 05. 
 
 
4.2.2.3 Combination of 12 Hour Experiments  
Figure 4-12 shows the combined data for 12-hour experiments. Here, the 
confluent cells show less resistance at 0.001 µg/mL than at 0.01 – 0.5 µg/mL. 
Also, 0.5 µg/mL appears to be less toxic than 0.25 µg/mL. For the 
semiconfluent cells, 0.001 µg/mL appears to be more toxic than 0.01 and 0.1 
µg/mL. Also, 2.5 µg/mL is observed to have less adverse affects for this cell 
density than at 1 µg/mL. 
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Figure 4-12. Combination of all 12 hour experiments conducted on CdO 
exposure, with doses ranging from 0.001 – 2.5 µg /mL. 
 
 
4.2.3 Toxicity over 6 Hours 
 
The following data reflect the effects of CdO exposure on rat 
hepatocyte cells over a period of 6 hours. The data was generated 
following completion of the MTT assay. The data is presented in order 
from the higher dose range (0.1 – 2.5) µg/mL to the lower dose range 
(0.001 – 1) µg/mL. 
 
4.2.3.1 High Dose Range 
 
Figure 4-13 shows results from a 6-hour exposure with the high dose. The 
confluent cells show more resistance at 0.5 µg/mL than at 0.25 µg/mL. 
Otherwise, a smooth dose-response curve is present. For the semiconfluent 
cells, 0.25 µg/mL CdO appears to have a slightly less adverse affect than 0.1 
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µg/mL, otherwise, a smooth dose-response curve is present. On average, the 
semiconfluent cells show more resistance than the confluent cells. 
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Figure 4-13.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 6 hour exposure ending on 24 Jan 05. 
 
 Figure 4-14 shows the results of a second 6-hour high dose experiment. 
The same observation made at 0.5 µg/mL in the previous experiment is also 
made here for both cell densities. This is the only observation disrupting the 
dose-response curve. On average, the semiconfluent cells show more 
resistance to the toxicant than the confluent cells. 
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Figure 4-14.  Effect of CdO, with doses ranging from 0.1 – 2.5 µg /mL, on 
hepatocytes following a 12 hour exposure ending on 26 Jan 05. 
 
4.2.3.2 Low Dose Range 
 
Figure 4-15 shows the results of a 6-hour low dose experiment. The 
confluent cells showed less resistance at 0.01 µg/mL than at 0.001 and 0.1 
µg/mL. The semiconfluent cells show some positive activity at 0.01 and 0.1 
µg/mL compared to the control cells. On average, the semiconfluent cells 
show more resistance than the confluent cells. 
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Figure 4-15.  Effect of CdO, with doses ranging from 0.001 – 1 µg /mL, on 
hepatocytes following a 6 hour exposure ending on 21 Jan 05. 
 
 Figure 4-16 shows the results of a second 6-hour low dose experiment. 
The confluent cells show positive activity for 0.001 and 0.1 µg/mL, with more 
growth at 0.1 µg/mL. However, 0.01 µg/mL shows a more adverse affect than 
either of the aforementioned doses. The semiconfluent cells show a rise in 
resistance to the CdO from 0.001 µg/mL to 0.1 µg/mL. 
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Figure 4-16.  Effect of CdO, with doses ranging from 0.001 – 1 µg /mL, on 
hepatocytes following a 6 hour exposure ending on 24 Jan 05. 
 
 Figure 4-17 shows the final 6-hour exposure with the low dose range. The 
confluent cells show a rise in resistance to the CdO from 0.001 – 0.1 µg/mL 
with positive activity observed at 0.1 µg/mL. The semiconfluent cells show 
slightly more resistance at 0.01 µg/mL than at 0.001 µg/mL. The same affect 
is observed at 0.1 µg/mL versus 0.001 µg/mL. On average, the confluent cells 
show more overall resistance to the toxin than the semiconfluent cells. 
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Figure 4-17.  Effect of CdO, with doses ranging from 0.001 – 1 µg /mL, on 
hepatocytes following a  6 hour exposure ending on 26 Jan 05. 
 
  
4.2.3.2 Combination of 6 Hour Experiments  
 
Figure 4-18 shows the combined data for 6-hour experiments. Here we see 
the confluent cells have almost no reaction to 0.001 and 0.1 µg/mL CdO. 
However, a decline in resistance is observed at 0.01 µg/mL. Also, 0.5 µg/mL 
is observed to have a less adverse affect than 0.25 µg/mL. The semiconfluent 
cells show less resistance at 0.01 µg/mL than at 0.001 and 0.1 µg/mL. Also, 
0.1 µg/mL shows a less adverse affect on this cell density than 0.001 µg/mL.   
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Figure 4-18. Combination of all 6 hour experiments conducted on CdO 
exposure, with doses ranging from 0.001 – 2.5 µg /mL. 
 
 
4.3 Discussion 
 
Figures 4-5, 4-12, and 4-18 depict the three combined sets of data (24, 12, 6 
hours) previously shown in the chapter, and are presented again here, together, for 
comparison as Figures 4-19, 4-20, and 4-21. 
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Figure 4-19. Combination of all 24 hour experiments conducted on CdO 
exposure, with doses ranging from 0.001 – 2.5 µg /mL. 
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Figure 4-20. Combination of all 12 hour experiments conducted on CdO 
exposure, with doses ranging from 0.001 – 2.5 µg /mL. 
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 Figure 4-21. Combination of all 6 hour experiments conducted on CdO 
exposure, with doses ranging from 0.001 – 2.5 µg /mL. 
 
 
 Tables 4-1 and 4-2 show the combination of all results from each 
experiment (for confluent cells and semiconfluent cells, respectively) with the 
numerical percent of control cells.  
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 Table 4-1. Combination of all experiments for confluent cells with numerical 
percent of control cells. 
 
Percent of Control Cells 
Dose (µg/mL CdO) 6-hour 12-hour 24-hour 
0 100 100 100 
0.001 98.19 70.77 87.14 
0.01 79.92 72.27 24.02 
0.1 96.96 82.92 101.75 
0.25 42.21 70.47 45.40 
0.5 50.38 71.62 58.86 
1.0 25.30 55.78 12.00 
2.5 15.56 38.03 3.94 
 
 
Table 4-2. Combination of all experiments for semi-confluent cells with 
numerical percent of control cells. 
 
Percent of Control Cells 
Dose (µg/mL CdO) 6-hour 12-hour 24-hour 
0 100 100 100 
0.001 83.15 80.95 84.82 
0.01 96.41 82.03 34.02 
0.1 94.56 83.80 75.16 
0.25 62.56 66.12 49.41 
0.5 56.01 62.69 50.95 
1.0 35.54 32.73 11.36 
2.5 17.57 36.15 3.38 
 
 The first observation to make would be that the CdO was, on average, 
more toxic to the cells after 24 hours than at any other end point. However, 
comparing the 12 hour and 6 hour data, the difference is not so obvious. While the 
lower doses (between 0.001 and 0.1 µg/mL) show less toxicity at 6 hours than at 
12 hours, as expected, the higher doses show the reverse. For example, in 
comparing the two end points at 2.5 µg/mL, it would seem the cells show a more 
adverse reaction at the end of 6 hours than at 12 hours. The same observation is 
made for 0.25 – 1 µg/mL. Also, out of the three combined sets of data, it appears 
the 6 -hour experiments show the smoothest dose-response curve. In other words, 
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as the doses get higher, the cells generally experience more fatalities, with a 
couple of exceptions at the lower doses. On average, for the entire study, the 
confluent cells showed more resistance to the cadmium oxide than the 
semiconfluent. However, the difference in resistance capability was very close. At 
no time during the entire experiment was a 100% fatality of the cells observed, 
though in some cases, the percent of control cells was less than 2%. 
 Approximately twice as many experiments as what is shown in this 
chapter were carried out or attempted to be carried out. The other half of the 
experiments not shown were excluded either because of data that was obviously 
too much of an outlier, or various technical problems in the lab prevented the 
experiments from reaching completion. 
 Comparing the results of this study to other in vitro studies is somewhat 
difficult. While there have been such studies performed and published, the field is 
still young enough to make finding suitable literature for comparison difficult. 
The literature cited in chapter two revealed studies accomplished for the express 
purpose of identifying hazard characteristics of various chemicals. However, 
these studies focused on different cell lines, other than hepatocytes, involved 
different chemicals and endpoints, and were not conducted in the same manner or 
with the same assays as was used in this thesis study. 
 In previous sections of this chapter, observations were made in each of the 
individual sets of data, which would require explanations. That is, explanations as 
to why the data may not have turned out the way one would expect, mainly, the 
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numerous variations and inconsistencies observed between individual 
experiments. Below are some arguments to help explain these observations.      
1. The spectrograph (described in chapter three) template may not have 
been set correctly, thus leading the researcher to paste data from the 
template to the Excel program incorrectly. For example, on many of 
the graphs, 0.5 ug/mL did not seem as toxic as 0.25 ug/mL. This could 
be a possible explanation.  
2. During almost every stage of an experiment, pipetting techniques were 
employed. Some pipetting is accomplished with an electric pipetter, 
some with manual pipettes. Consequently, pipetting could vary slightly 
from one experiment to the next. 
3. During cell culture and trypsonization, the cells were observed to grow 
often at dramatically different rates from day to day, including growth 
after seeding in the exposure plates. For example, after seeding in the 
6-well plates, cells could have grown faster over a 24 hour period on 
one day, than on the next day. (Seeding takes place 24 hours prior to 
exposure.) This being the case, it’s possible there was a slight 
difference in the cell count on different days during exposure, causing 
slightly different reactions. 
4. The method for conducting the MTT assay was described in chapter 
three. During the course of the research, the assay would sometimes 
react more slowly than other times, thus varying the length of time the 
cells were incubated with the MTT. For example, some cells  
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incubated twice as long as usual but the MTT had still not had the 
usual effect. 
5. On a daily basis, bottles of media, flasks with cells, CdO solutions, and 
plates with cells would be carried and handled by hand in a nonsterile 
environment for several seconds (through the lab) before and after 
being placed under the hood. In this situation, certain bacteria or germs 
could have passed to the media or cells. Bacteria contamination is 
possible during exposure as well. While there is no strong evidence to 
support contamination in the data, the possibility should not be ruled 
out. 
 
4.4 Summary 
The data description and analysis chapter has discussed the results of hepatocyte 
cell exposure to cadmium oxide using in vitro experimentation. The study 
attempted to show the toxicity of CdO at different doses and times, as well as the 
affect of the toxicity on two different cell densities. First, the affect of CdO on the 
cells over a period of 24 hours was analyzed, followed by 12 hours, and 6 hours. 
The chapter concludes with statements of possible reasons for variations in the 
data.  
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V. Conclusions and Recommendations 
 
5.1 Overview 
In vitro experimentation has been used to determine toxicity and 
environmental regulations for a number of chemicals. Several cell lines have been 
exposed to known or suspected toxins, some of these cells from animals, some 
human. In the process of studying the effects of toxins on mammalian cells, the 
research ultimately involved extrapolating the data to the human physiological 
system. That was in fact, one important reason for the research conducted in this 
thesis. Presenting a range of doses of a suspected human carcinogen, in this case, 
cadmium oxide, and the affects of exposure on rat liver cells, better equips 
decision makers to draw conclusions about acceptable exposure levels.  
This research effort provides data for a small part of this on-going field of 
study. It will provide a basis for comparison in future experiments carried out by 
the Air Force Research Laboratory. Long after this thesis is accomplished, there 
will continue to be studies undertaken on cadmium oxide toxicity and its effects 
on the human body.  
Relating or comparing the results of this research to the limited sources of 
literature proved difficult. Although there was a significant amount of data collected, 
given the amount of time available, there were some obstacles to overcome in the lab 
for a first-time biological and toxicological researcher.  
Altogether, this work is a first step in understanding the effects of cadmium oxide 
on rat liver cells. As with all research efforts, the results of this study are prone to 
56 
their own uncertainty. The topic is certainly not exhaustive but should provide the 
reader with a feel for the studies limitations in the previous chapters. 
5.2 Conclusions 
The conclusions discussed will answer the following research questions originally 
stated in the first chapter, while the first research question was answered in the 
literature review: 
1. What is the cellular toxicity of cadmium oxide particles? 
2. What is the effect of cell density on cadmium oxide toxicity? 
 5.2.1 Comparing Experiments 
  The most obvious conclusion to draw from this study is that cadmium oxide is more 
toxic to liver cells after 24 hours than after 12 or 6 hours. At some of the points 
during the experiments, a positive growth was observed at certain doses. In other 
words, the cells would actually grow beyond the density of the control cells after 
being exposed. This observation was made most often during the 6 hour experiments, 
at a dose of 0.1 ug/mL. However, there were other isolated incidents of this 
phenomenon during the 12 hour and 24 hour  experiments, at different doses. Some of 
these cases may be a direct result of the possibility that a small dose of cadmium 
oxide actually does provide a positive growth environment over a limited period of 
time. Another possibility, however, would be the fact that no two experiments were 
carried out in exactly the same manner, due to technical complications in the lab 
and/or lack of experience on the part of the researcher. For example, preparing and 
pipetting the cadmium oxide solutions, and seeding the exposure plates with proper 
cell densities may have differed from one experiment to the next. This would result in 
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the differences observed in the data. Unfortunately, the time required to duplicate 
enough experiments to reach a solid conclusion on this point, was outside the scope 
of this thesis.  
5.2.2  Comparing Effect on Cell Density 
Another point to make after observing the data is that the confluent cells (1,000,000 
cells/mL) were more resistant to the CdO than the semiconfluent cells (500,000 
cells/mL) because there existed more particles per cell in the semiconfluent situation. 
However, the difference between the two resistance capabilities was limited. At first 
glance, it would seem the two cell densities had almost equal resistance, but not at the 
same doses. The explanation for this may become more apparent if the researcher was 
able to repeat the experiments. In fact, through repetitive experiments, a very clear 
average of a cell density’s reaction to the toxin may easily be seen. The evidence in 
the data presented does not strongly support the conclusion that CdO does not affect 
confluent cells any differently than semiconfluent cells. However, since repetition 
was not available, drawing conclusions as to the affects of CdO on cell densities may 
prove to be yet another difficulty within this research.  
5.3 Recommendations 
 5.3.1   Research Time 
From the beginning of this research, it was apparent that the greatest challenge 
would be accomplishing the objectives of the research within the time allotted. Since 
the researcher had no experience in conducting experiments of this nature, 
considerable time was needed for training and preparation. In addition, the Air Force 
Research Laboratory requires various mandatory training sessions. At least 12 months 
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of lab work, after the training period, would be ideal for achieving these experiments, 
and also provide extra time for replicate studies should the need arise. 
5.3.2  Hepatocytes 
Hepatocyte cells seem to grow and culture very well. There were no major or 
irreparable incidents in culturing the hepatocyte cell line. Studying the use of other 
cells was outside the scope of this thesis. However, Dr. Hussain at the Air Force 
Research Laboratory confirms that hepatocytes are among the easiest cell lines to 
culture. Sometimes, for example, macrophages (lung cells) may not grow as fast as 
hepatocytes. Therefore, a researcher with either a short time frame or a lack of 
experience would find that hepatocytes may be the cell line of choice.    
5.3.3  Number of Experiments 
At the completion of the study, some of the data was excluded, if it seemed to 
present too many outliers. For this reason, conducting more experiments than what 
the objective calls for would be recommended. Perhaps two experiments for every 
one would be suitable. This should be taken into consideration when planning the 
timeframe. 
5.3.4 Other Related Studies 
There is a long road ahead for studies on cadmium oxide and other forms of 
cadmium. Certainly, additional studies on the affects of the chemical on hepatocytes 
are called for. However, there are many other areas of the human body, which a toxic 
compound can affect. A useful study for professional researchers in general would be 
comparing the affects of cadmium oxide, using in vitro methods, on different cells, 
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and compare the results. This would go a long way in determining exposure levels to 
airborne particles versus exposure from soil or food.  
In addition, there are many other doses and end points to explore in cadmium 
oxide studies. For example, long- term affects of low doses was not studied in this 
thesis. Other cadmium compounds, different assays, and lower cell densities should 
also be studied. Lastly, a positive control should be used in future experiments. For 
example, a toxicant with a known adverse effect should be used in the same 
experiment, to compare the toxicity. 
5.4 Summary 
While the experiments conducted in this study don’t lead to definitive answers, 
the results certainly offer a starting point and/or comparisons for future research 
involving cadmium oxide toxicity. Ultimately, this research will contribute to the 
overall efforts to determine safer and more accurate exposure levels of cadmium 
oxide for the general population. Though further research is needed in the general 
field of in vitro toxicology, the method is currently  gaining acceptance as a credible 
tool for helping scientists determine the toxicity of a wide range of chemicals.  
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